Clinical Trial Update: Danish Carvedilol Study in Portal Hypertension [Phase 3]

View source ↗

Summary

A Danish Phase 3 trial evaluating carvedilol for portal hypertension in cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Portal Hypertension

Drugs mentioned

• Carvedilol (Coreg) (carvedilol)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Cirrhosis, Portal Hypertension | Phase 3 | Status: COMPLETED